Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
about
Corticosteroids for managing tuberculous meningitisIntegrated therapy for HIV and tuberculosisTuberculous meningitis is a major cause of mortality and morbidity in adults with central nervous system infections in Kota Kinabalu, Sabah, Malaysia: an observational studySix months therapy for tuberculous meningitisThe Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study.Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study.Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.Suboptimal Exposure to Anti-TB Drugs in a TBM/HIV+ Population is not Related to Anti-retroviral Therapy.Tuberculosis Meningitis.Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?Neurological complications after tuberculous meningitis in a multi-state cohort in the United States.Innovative Methods to Manage, Detect, and Prevent Tuberculosis.Infections of the Central Nervous System in Returning Travelers and Immigrants.Central nervous system Tuberculosis in a man from Cambodia with worsening headachesTuberculous Meningitis in Children and Adults: New Insights for an Ancient Foe.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Prognostic Models for 9-Month Mortality in Tuberculous Meningitis.A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.Treatment of Tuberculous Meningitis and Its Complications in Adults.Tuberculous meningitis: a roadmap for advancing basic and translational research.Can aspirin help?Mutations of rpob Gene Associated with Rifampin Resistance among Mycobacterium Tuberculosis Isolated in Tuberculosis Regional Reference Laboratory in Northeast of Iran during 2015–2016.High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaThe importance of clinical pharmacokinetic-pharmacodynamic studies in unraveling the determinants of early and late tuberculosis outcomesRifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcriptionAdjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trialTuberculous meningitisAdjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trialFunctional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study
P2860
Q24185853-76F355F0-9AC1-4456-9AE8-AEB4A8078B7AQ26749428-34E17445-FB7F-4525-8E16-8B45AB682AF5Q27469054-0F68B911-FFB2-4F91-A29E-3E0B6CDA26C8Q28074247-5C52BFD9-52D1-4970-8B12-C62C9131D993Q36145111-8F7D8FD3-9AE8-42DC-A8E5-83380ED2A6ADQ36166714-D1786AB7-854A-4F2A-AA21-16A87B0FCA08Q36349886-5E611211-50C7-4B2C-8C0D-D4F3B1819B5CQ37507802-2639FF56-EC4E-4A52-AEF9-DAA37411AB00Q39032302-400D2A4A-BFED-41C4-99B6-503D467C690EQ39062016-4768BE22-E56E-4CE2-8332-511C4FCAFF67Q39523555-53EC44FA-9062-4633-91E9-C5408D5EFA93Q39539828-216C970B-1DD2-4D22-A4C9-CEFAE419D078Q40046111-59374922-F01A-45DD-94CC-DA023859B945Q40124133-95391BE0-9F16-463D-A016-C39019B864E4Q40202149-E4A1E47C-CE24-49D4-922A-99D855C5885AQ40284504-2057C4B3-02E1-4FFB-8BBE-0B6D238C275DQ40444755-052873C1-C04D-447C-A40A-67EC58A3B258Q41924988-D005AF4B-6F3A-4F6D-ADC0-21884E57FF3AQ42279526-1414117F-D541-4851-9B97-908CFB698FB9Q47192301-FBBE2E2D-2EF5-466C-BD10-769D43DD4726Q47332682-536695E2-0DD8-4DCE-80B5-4DAEE26AC6BBQ50065137-8CDC8F95-B8B8-4BA1-A5D5-567A9EF12291Q51747428-5F6A2DA7-6CFF-41F7-B769-FB9DA93FF7D8Q52680275-FB9C6D96-3C94-4A8A-ADB9-F9BAE8E19F98Q54206218-FD499752-8E8C-4C09-8702-9BE27604EE7CQ55162614-4699AF13-7322-44E8-83C3-407AA10CE565Q55440809-896BF8A4-32D8-44A6-9037-DE9FE740C326Q56911375-D71393F6-F6C4-4ED7-A526-3FACD7631AE0Q56912105-6735029F-DE5F-4AD9-BB23-C2F251854786Q57152709-9AE0C7A3-201F-44CD-B261-5C5096C44E64Q57476558-CDEDA4A3-EAF1-4453-9A89-40F45A86DDC4Q57496816-5D75C93F-4C57-4BA6-A641-E05E0EFD8894Q57827115-11370493-7B0F-4329-8E3D-2A449F1C089EQ58575535-1C0AE74C-96E1-4A1E-8EE9-4AE4F7B9E6B9Q58770575-BA34FDAF-ABFD-4B61-A4B8-0B1B3593E27E
P2860
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@en
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@nl
type
label
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@en
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@nl
prefLabel
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@en
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@nl
P2093
P50
P356
P1476
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
@en
P2093
A Dorothee Heemskerk
Dang T M Ha
Jeremy N Day
Le T Phong
Nguyen D Bang
Nguyen H Dung
Nguyen H Lan
Nguyen H Phu
Nguyen N Lan
Nguyen N Vien
P304
P356
10.1056/NEJMOA1507062
P407
P577
2016-01-01T00:00:00Z